Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors

• Published in: Metabolic engineering 2017-09, Vol.43 (Pt B), p.187-197
• Main Authors: Lorendeau, Doriane, Rinaldi, Gianmarco, Boon, Ruben, Spincemaille, Pieter, Metzger, Kristine, Jäger, Christian, Christen, Stefan, Dong, Xiangyi, Kuenen, Sabine, Voordeckers, Karin, Verstreken, Patrik, Cassiman, David, Vermeersch, Pieter, Verfaillie, Catherine, Hiller, Karsten, Fendt, Sarah-Maria
• Format: Article
• Language: English
• Subjects: 13C metabolic flux analysis; Ataxia; Cell Line, Tumor; Complex I of the electron transport chain; Electron Transport Complex I - genetics; Electron Transport Complex I - metabolism; Gastrointestinal stromal tumors; Humans; Leigh syndrome; Leukodystrophy; Mitochondrial respiration; Mutation; Neoplasm Proteins - genetics; Neoplasm Proteins - metabolism; Neoplasms - enzymology; Neoplasms - genetics; Neoplasms - pathology; Neurons - enzymology; Neurons - pathology; Paraganglioma; Pyruvate carboxylase; Reductive glutamine metabolism; SDH mutations; Succinate dehydrogenase; Succinate Dehydrogenase - genetics; Succinate Dehydrogenase - metabolism
• ISSN: 1096-7176; 1096-7184
• DOI: 10.1016/j.ymben.2016.11.005

Mutations in succinate dehydrogenase (SDH) are associated with tumor development and neurodegenerative diseases. Only in tumors, loss of SDH activity is accompanied with the loss of complex I activity. Yet, it remains unknown whether the metabolic phenotype of SDH mutant tumors is driven by loss of complex I function, and whether this contributes to the peculiarity of tumor development versus neurodegeneration. We addressed this question by decoupling loss of SDH and complex I activity in cancer cells and neurons. We found that sole loss of SDH activity was not sufficient to recapitulate the metabolic phenotype of SDH mutant tumors, because it failed to decrease mitochondrial respiration and to activate reductive glutamine metabolism. These metabolic phenotypes were only induced upon the additional loss of complex I activity. Thus, we show that complex I function defines the metabolic differences between SDH mutation associated tumors and neurodegenerative diseases, which could open novel therapeutic options against both diseases. [Display omitted] •Dual loss of SDH and complex I is required for the metabolism of SDH mutant tumors.•Loss of complex I impairs respiration in SDH-mutant cells.•Loss of complex I induces reductive glutamine metabolism in SDH-mutant cells.•Loss of complex I distinguishes SDH-mutant tumors vs SDH-mutant neurodegeneration.•Cells can sustain respiration upon a TCA cycle truncation at the level of SDH.